Stock Information
AbbVie Inc. (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $521,352.61 mil
Piotroski score: 8
PE Ratio: 48.46
EPS (TTM): 5.83
Revenue (TTM): $37.25 M
Dividend Yield: 4.47%
ROE: 95.59%
Latest News
-
$500,000 in AbbVie and Gilead Could Pay More Than $11,000 a Year in Dividends
Sat, Nov 21, 2026 6:07 PM
-
AbbVie (ABBV) Stock Just Got a 5.2% Dividend Increase. Here's How Many Shares You Need to Generate $1,000 a Year.
Sat, Nov 21, 2026 1:30 PM
-
Is Solid Tumor Partnership Altering The Investment Case For AbbVie (ABBV)?
Sat, Nov 21, 2026 12:12 AM
-
5 High-Yield Healthcare Stocks for a Tax-Free Roth IRA Income Stream
Fri, Nov 20, 2026 5:15 PM
-
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
Fri, Nov 20, 2026 4:20 PM
-
Should You Buy Jazz Pharmaceuticals Stock For Its Cash?
Fri, Nov 20, 2026 3:27 PM
-
Senate Passes Landmark Permitting Bill. Here’s Who Could Benefit.
Fri, Nov 20, 2026 3:20 PM
-
Oncology Clinical Trials - Global Strategic Business Report 2026: Secure Share of a $6 Billion Revenue Surge by 2032 as AbbVie, AstraZeneca, ICON, Merck, and Roche Accelerate AI-Led Trials
Fri, Nov 20, 2026 3:01 PM
-
Should You Buy Bristol Myers Squibb Stock At Today's Discount?
Fri, Nov 20, 2026 2:51 PM
-
Jim Cramer Says Cardinal Health Is “the Stock That Is Made for This Moment”
Fri, Nov 20, 2026 2:47 PM
Key Financials
Financial data not available